The biopharmaceutical industry is finally coming of age and we are seeing more biologic therapies reaching the clinic to treat a variety of ailments. These range from rare, previously undruggable ...

As precision medicine drives the development of more targeted drugs, demands are increasing for more complex biomarker analyses – and so researchers are striving to develop new techniques that are ...